Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
228.62-1.85 (-0.80%)
As of 9:56 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close230.47
Bid228.21 x 100
Ask228.41 x 200
Day's Range228.10 - 232.19
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap90.52B
P/E Ratio (ttm)21.77
Avg Vol (3m)3,318,265
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire2 hours ago

    Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans

    DUBLIN, Oct. 24, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to improving outcomes and meeting critical needs in infectious diseases, will present new ...

  • Barrons.com2 days ago

    [$$] Allergan's Upside: 20%-30%

    Despite Allergan’s robust drug pipeline and growing revenue and profits, its shares have fallen by a third from its all-time high of $340 in mid-2015 to Friday’s $230.47. The market’s disenchantment with this maker of products such as wrinkle-treatment Botox has more to do with industry issues and sentiment than company woes. Last April, investors bailed out after Pfizer’s (PFE) proposed $150 billion purchase of Allergan disintegrated, following opposition to tax aversions by the Obama administration.

  • Gilead NASH Drug 'Active And Promising,' But Lagging Intercept
    Investor's Business Daily3 days ago

    Gilead NASH Drug 'Active And Promising,' But Lagging Intercept

    Gilead's NASH drug is "clearly active and promising," but Intercept Pharmaceuticals remains one to two years ahead, RBC says.